Cembre (CMB) investor relations material

Executive summary

• Consolidated sales for H1 2026 reached €141.2 million, up 13.6% year-over-year, with strong growth in Germany (+18.1%), USA (+54.3%), Spain (+13.1%), and all markets except France.

• Net profit rose 27.1% to €28.8 million, representing a 20.4% margin on sales.

• EBITDA margin improved to 33.5% from 31.0% in the prior year.

• The Group maintained a robust financial position despite significant dividend payments and capital expenditures.

• The company maintained strong growth momentum into August, with consolidated revenues up 14.3% for the first eight months of 2026.

Financial highlights

• EBITDA reached €47.3 million, up 22.8% year-over-year, with margin at 33.5%.

• EBIT increased 25.4% to €39.6 million, representing 28.0% of sales.

• Net financial position was negative €31.2 million at June 30, 2026, impacted by €34.6 million in dividends and €11.0 million in capex.

• Net operating working capital rose to €114.5 million, 46.9% of sales.

• Basic and diluted earnings per share were €1.71, up from €1.34.

Outlook and guidance

• Management expects consolidated revenues and economic results to remain positive for the full year 2026, despite economic and geopolitical uncertainties.

• Focus on business development through new products, R&D, and expanding distributor channels, especially in the US and Germany.

• Continued investment in automation and manufacturing efficiency to drive cost management and growth.